Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure.
about
Combining targeted therapies: practical issues to consider at the bench and bedside.The bone marrow microenvironment as a sanctuary for minimal residual disease in CML.Use of dasatinib and nilotinib in imatinib-resistant chronic myeloid leukemia: translating preclinical findings to clinical practice.New drugs for chronic myelogenous leukemia.Current status of agents active against the T315I chronic myeloid leukemia phenotype.Suppression of carboxylesterases by imatinib mediated by the down-regulation of pregnane X receptor.Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitors.Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational anNon ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia.Therapy of Newly Diagnosed and Chronic-Phase Chronic Myeloid Leukemia
P2860
Q35583672-2FFA7A2B-DD83-4502-A7FE-40559307C2F5Q35773205-F96619B6-69C7-4E94-92F5-9411034F4DBEQ37663655-95D7AE53-07D5-42E0-8B90-86577415F28BQ37843769-BD4452BA-2FF1-4684-A073-E743CA0EDEBCQ37847179-012A05EA-DA65-47AC-8841-4A8E60C7A37CQ38995804-B8776248-E82B-49D6-9589-342755FBA0E7Q39464336-D62E8339-733C-4B5A-81EC-CF0E3479BF1AQ41902379-9FB696B7-5F8E-4D2B-AF54-035A9CA9F3F3Q49887884-B055BEB1-AF99-430E-83BA-0367DB5F3155Q58023832-715723B9-0AB4-460B-887A-E94523CCDB27
P2860
Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Phase 1 study of tipifarnib in ...... phase after imatinib failure.
@ast
Phase 1 study of tipifarnib in ...... phase after imatinib failure.
@en
type
label
Phase 1 study of tipifarnib in ...... phase after imatinib failure.
@ast
Phase 1 study of tipifarnib in ...... phase after imatinib failure.
@en
prefLabel
Phase 1 study of tipifarnib in ...... phase after imatinib failure.
@ast
Phase 1 study of tipifarnib in ...... phase after imatinib failure.
@en
P2093
P50
P356
P1433
P1476
Phase 1 study of tipifarnib in ...... phase after imatinib failure.
@en
P2093
Alfonso Quintás-Cardama
Deborah Thomas
Theresa Ebarb
P304
P356
10.1002/CNCR.23006
P407
P50
P577
2007-11-01T00:00:00Z